No registrations found.
ID
Source
Health condition
autoimmune hepatitis, drug-induced liver injury, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Sponsors and support
Intervention
Outcome measures
Primary outcome
Immunophenotype of intrahepatic leucocytes.
Secondary outcome
Histology outcome
Study design
Baseline, 6 months follow-up.
Intervention
One extra needle passage during a liver biopsy that is part of usual care.
[default]
The Netherlands
[default]
The Netherlands
Inclusion criteria
Indication for a biopsy for the diagnosis or monitoring of; AIH, DILI, NAFL or NASH
Eligible for liver biopsy
¡Ý 18 years old
Provide informed consent
Exclusion criteria
Contraindication for liver biopsy, determined by the clinician.
Current infectious disease.
Clinically relevant cardiovascular, pulmonary, or renal disease.
Medications with possible immune-modulating effects (e.g., steroids).
(a history of) alcohol or drug abuse
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL6815 |
| NTR-old | NTR7002 |
| Other | : |